Table of Contents
Chromatography Research International
Volume 2011, Article ID 278923, 5 pages
Research Article

Validated Stability Indicating HPTLC Method for the Determination of Dutasteride in Pharmaceutical Dosage Forms

Department of Pharmachemistry, S. K. Patel College of Pharmaceutical Education and Research, Ganpat University, Kherva, Gujarat, Mehsana 382711, India

Received 12 March 2011; Accepted 12 May 2011

Academic Editor: Osama Y. Al-Dirbashi

Copyright © 2011 Dipti B. Patel et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. The Merck Index, Merck Research Laboratories, Division of Merck & Co., Whitehouse Station, NJ, USA, 14th edition, 2006.
  2. S. C. Sweetman, Martindale: The Complete Drug Reference, Pharamceutical Press., The Royal Pharmaceutical Society of great Britain, 34th edition, 2005.
  3. C. Page, M. Walker, and M. Curtis, Integrated Pharmacology, Mosby, New York, NY, USA, 2002.
  4. M. Marberger, “Drug insight: 5α-reductase inhibitors for the treatment of benign prostatic hyperplasia,” Nature Clinical Practice Urology, vol. 3, no. 9, pp. 495–503, 2006. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  5. S. S. Kamat, V. B. Choudhari, V. T. Vele, and S. S. Prabhune, “Determination of dutasteride by LC: validation and application of the method,” Chromatographia, vol. 67, no. 11–12, pp. 911–916, 2008. View at Publisher · View at Google Scholar · View at Scopus
  6. D. V. S. Rao and P. Radhakrishnanand, “Stress degradation studies on dutasteride and development of a stability-indicating HPLC assay method for bulk drug and pharmaceutical dosage form,” Chromatographia, vol. 67, no. 9–10, pp. 841–845, 2008. View at Publisher · View at Google Scholar · View at Scopus
  7. N. V. S. Ramakrishna, K. N. Vishwottam, S. Puran, M. Koteshwara, S. Manoj, and M. Santosh, “Selective and rapid liquid chromatography-tandem mass spectrometry assay of dutasteride in human plasma,” Journal of Chromatography B, vol. 809, no. 1, pp. 117–124, 2004. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  8. S. K. Sudhir, B. C. Vishal, T. V. Vinayak, and S. P. Swarup, “Determination of dutasteride from its bulk drug and pharmaceutical preparations by high performance thin layer chromatography,” Asian Journal of Chemistry, vol. 20, no. 7, pp. 5514–5518, 2008. View at Google Scholar · View at Scopus
  9. S. Agarwal, K. V. Gowda, A. K. Sarkar et al., “Simultaneous determination of tamsulosin and dutasteride in human plasma by LC-MS-MS,” Chromatographia, vol. 67, no. 11–12, pp. 893–903, 2008. View at Publisher · View at Google Scholar · View at Scopus
  10. V. V. Pande, “Simultaneous estimation of Tamsulosin hydrochloride and Dutasteride in combined dosage form by UV spectroscopy method,” Journal of Pharmacy Research, vol. 3, p. 15, 2009. View at Google Scholar
  11. “Validation of analytical methods: methodology,” in Proceedings of the 3rd International Conference on Harmonization of Technical Requirements for Registration of Pharmaceuticals for Human Use (ICH '96) Guideline on Validation of Analytical Procedure-Methodology, Geneva, Switzerland, 1996.